In comparison to HPMECs treated with TNFα, HPASMC showed a far greater induction of IL-8 mRNA in control and PAH cells (30-fold in control and 20-fold in PAH cells). This evidence concerns the gene CXCL8 and pulmonary arterial hypertension.